Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Adrian Adams currently holds 17,609 shares of Aralez Pharmaceuticals Inc. (ARLZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adrian Adams has been a net buyer of ARLZ stock. They have purchased $10.2M and sold $1.4M worth of shares.
Adrian Adams's most recent insider trade was on Oct 23, 2025, when they sold 4,267 shares at $0.00 per share.
Adrian Adams serves as Executive at Aralez Pharmaceuticals Inc. (ARLZ). They have executed 63 insider transactions totaling $11.5M over their tenure at the company.
Adrian Adams holds the position of Executive at Aralez Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Adrian Adams has shown a buying trading pattern, with $10.2M in total purchases and $1.4M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Adrian Adams was on Jan 29, 2015, when they sold $4.4M worth of AUXL shares. This transaction involved 120,134 shares at $36.53 per share.
Adrian Adams currently owns 17,609 shares of Aralez Pharmaceuticals Inc. (ARLZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Adrian Adams's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Adrian Adams has 63 Form 4 filings on record as an insider at Aralez Pharmaceuticals Inc..
Set alerts for Adrian Adams and 40,000+ other insiders.